Atherectomy for peripheral artery disease

Table of content

1.    Introduction and summary
2.    Executive summary table
3.    Contents
4.    Methodology
5.    Reimbursement analysis in Austria
5.1.    Overview of the reimbursement system
5.2.    Reimbursement for percutaneous atherectomy
5.2.1.    Procedure coding
5.2.1.1.    Coding of atherectomy
5.2.1.2.    Coding of atherectomy in combination with angioplasty and insertion of stent
5.2.2.    Diagnosis coding
5.2.3.    Payment mechanism and reimbursement tariffs
5.2.3.1.    Reimbursement of atherectomy
5.2.3.2.    Reimbursement of atherectomy in combination with angioplasty and insertion of stent
6.    Reimbursement analysis in Belgium
6.1.    Overview of the reimbursement system
6.2.    Reimbursement for percutaneous atherectomy
6.2.1.    Procedure and material coding 
6.2.1.1.    Procedure and material coding of percutaneous transluminal atherectomy
6.2.1.2.    Procedure and material coding for surgical endarterectomy
6.2.2.    Payment mechanism and reimbursement tariffs
7.    Reimbursement analysis in Denmark
7.1.    Overview of the reimbursement system
7.2.    Reimbursement for percutaneous atherectomy
7.2.1.    Procedure coding 
7.2.2.    Diagnosis coding
7.2.3.    Payment mechanism and reimbursement tariffs
8.    Reimbursement analysis in England
8.1.    Overview of the reimbursement system
8.2.    Reimbursement for percutaneous atherectomy
8.2.1.    Procedure coding 
8.2.1.1.    Coding of atherectomy
8.2.1.2.    Coding of angioplasty and insertion of stent
8.2.2.    Diagnosis coding
8.2.3.    Payment mechanism and reimbursement tariffs
8.2.3.1.    Reimbursement for atherectomy
8.2.3.2.    Reimbursement for atherectomy in combination with angioplasty
8.2.3.3.    Reimbursement for atherectomy in combination with angioplasty with insertion of stent
8.2.4.    Policy considerations 
8.2.4.1.    Health technology assessment of percutaneous atherectomy by the National Institute for Health and Care Excellence 
8.2.4.2.    Commissioning of percutaneous atherectomy
9.    Reimbursement analysis in France
9.1.    Overview of the reimbursement system
9.2.    Reimbursement for percutaneous atherectomy
10.    Reimbursement analysis in Germany
10.1.    Overview of the reimbursement system
10.2.    Reimbursement for percutaneous atherectomy
10.2.1.    Procedure coding 
10.2.1.1.    Coding of atherectomy
10.2.1.2.    Coding of atherectomy in combination with angioplasty and insertion of stent
10.2.2.    Diagnosis coding
10.2.3.    Payment mechanism and reimbursement tariffs in hospital setting
10.2.3.1.    Reimbursement for atherectomy
10.2.3.2.    Reimbursement for atherectomy in combination with angioplasty and insertion of stent 
10.2.4.    Payment mechanism and reimbursement tariffs in day case setting
10.2.5.    Policy considerations
11.    Reimbursement analysis in Italy
11.1.    Overview of the reimbursement system
11.2.    Reimbursement for percutaneous atherectomy
11.2.1.    Procedure coding 
11.2.1.1.    Coding of atherectomy
11.2.1.2.    Coding of atherectomy in combination with angioplasty and insertion of stent
11.2.2.    Diagnosis coding
11.2.3.    Payment mechanism and reimbursement tariffs 
11.2.3.1.    Reimbursement for atherectomy
11.2.3.2.    Reimbursement for atherectomy in combination with angioplasty and insertion of stent 
12.    Reimbursement analysis in the Netherlands
12.1.    Overview of the reimbursement system
12.2.    Reimbursement for percutaneous atherectomy
12.2.1.    Procedure coding
12.2.1.1.    Coding of atherectomy
12.2.1.2.    Coding of atherectomy in combination with angioplasty and insertion of stent
12.2.2.    Material coding
12.2.3.    Diagnosis coding
12.2.4.    Payment mechanism and reimbursement tariffs
12.2.4.1.    Reimbursement for atherectomy
12.2.4.2.    Reimbursement for atherectomy in combination with angioplasty
12.2.4.3.    Reimbursement for atherectomy in combination with angioplasty with insertion of stent
12.2.5.    Policy considerations
12.2.6.    Health technology assessment by National Healthcare Institute
13.    Reimbursement analysis in Norway
13.1.    Overview of the reimbursement system
13.2.    Reimbursement for percutaneous atherectomy
13.2.1.    Procedure coding 
13.2.2.    Diagnosis coding
13.2.3.    Payment mechanism and reimbursement tariffs 
13.2.3.1.    Reimbursement using procedure codes for “other image-guided interventions”
13.2.3.2.    Reimbursement for surgical endarterectomy
14.    Reimbursement analysis in Sweden
14.1.    Overview of the reimbursement system
14.2.    Reimbursement for percutaneous atherectomy
14.2.1.    Procedure coding 
14.2.2.    Diagnosis coding
14.2.3.    Payment mechanism and reimbursement tariffs 
15.    Reimbursement analysis in Switzerland
15.1.    Overview of the reimbursement system
15.2.    Reimbursement for percutaneous atherectomy
15.2.1.    Procedure coding 
15.2.1.1.    Coding of atherectomy
15.2.1.2.    Coding of atherectomy in combination with angioplasty and insertion of stent
15.2.2.    Diagnosis coding
15.2.3.    Payment mechanism and reimbursement tariffs in hospital setting
15.2.3.1.    Reimbursement for atherectomy
15.2.3.2.    Reimbursement for atherectomy in combination with angioplasty with insertion of stent
15.2.4.    Payment mechanism and reimbursement tariffs in day case
15.2.4.1.    Reimbursement for atherectomy
15.2.4.2.    Reimbursement for atherectomy in combination with angioplasty with insertion of stent
15.2.5.    Policy considerations 
16.    Disclaimer